| Title | Cancer Prevention Research in China |
| Authors | Yu, Siwang Yang, Chung S. Li, Junyao You, Weicheng Chen, Jianguo Cao, Ya Dong, Zigang Qiao, Youlin |
| Affiliation | Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China. Rutgers State Univ, Dept Chem Biol, Piscataway, NJ 08854 USA. Rutgers State Univ, Ctr Canc Prevent Res, Piscataway, NJ 08854 USA. Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China. Peking Univ, Canc Hosp & Inst, Beijing 100191, Peoples R China. Nantong Univ, Liver Canc Inst, Qidong Liver Canc Inst, Nantong, Jiangsu, Peoples R China. Cent S Univ, Canc Res Inst, Changsha, Hunan, Peoples R China. Univ Minnesota, Hormel Inst, Austin, MN 55912 USA. Chinese Acad Med Sci, Natl Canc Ctr, Beijing 100730, Peoples R China. Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China. Peking Univ, Hlth Sci Ctr, Dept Biol Chem, Sch Pharmaceut Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China. |
| Keywords | EPSTEIN-BARR-VIRUS PRECANCEROUS GASTRIC-LESIONS NUTRITION INTERVENTION TRIALS ESTROGEN-RECEPTOR MODULATORS RANDOMIZED CONTROLLED-TRIAL NATIONAL PREVALENCE SURVEY DISEASE-SPECIFIC MORTALITY AFLATOXIN-DNA ADDUCTS REPUBLIC-OF-CHINA NASOPHARYNGEAL CARCINOMA |
| Issue Date | 2015 |
| Publisher | CANCER PREVENTION RESEARCH |
| Citation | CANCER PREVENTION RESEARCH.2015,8,(8),662-674. |
| Abstract | Although cancer incidence and mortality rates in the United States and some European countries have started to decrease, those in developing countries are increasing. China, the most populous developing country, is facing a serious challenge from cancer. Cancer incidence has been increasing for decades, and cancer is the leading cause of death in China. In 2012, the cancer incidence was 174.0 per 100,000, and the cancer mortality was 122.2 per 100,000 in China. In addition to the still-prevalent traditional Chinese cancers of the stomach, liver, esophagus, cervix, and nasopharynx, the incidence of "Western" cancers such those of the lung, breast, and colorectum has increased alarmingly in recent years. These increases are likely due to the lifestyle and environmental changes associated with rapid economic development and population aging. More importantly, a large portion of these cancers are preventable. Researchers in China have made important contributions to cancer prevention research, especially in the traditional Chinese cancers. More cancer prevention research and measures, especially on the major emerging cancers, are urgently needed. This review article highlights some of the past achievements and present needs in cancer prevention research in China and suggests important areas for future studies. (C) 2015 AACR. |
| URI | http://hdl.handle.net/20.500.11897/417723 |
| ISSN | 1940-6207 |
| DOI | 10.1158/1940-6207.CAPR-14-0469 |
| Indexed | SCI(E) PubMed |
| Appears in Collections: | 药学院 北京肿瘤医院 天然药物与仿生药物国家重点实验室 |
